FDAs May 2026 reviews identified substantial characterisation, effectiveness and safety gaps
Many of our patients report feeling more alert and focused after starting these injections
If current trends continue, this copper peptide could play a major role in dermatology
Mounjaro is used for weight loss and is found under the same name to treat type 2 diabetes
Pewnie z czasem bdzie lepiej Ase 01:41, 2026-08-04 Nowy bar mleczny na Ursynowie
Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript